93 1177 Pill - white round, 11mm
Pill with imprint 93 1177 is White, Round and has been identified as Neomycin Sulfate 500 mg. It is supplied by Teva Pharmaceuticals USA.
Neomycin is used in the treatment of Hepatic Encephalopathy; Bowel Preparation; Hepatic Coma; Diarrhea and belongs to the drug class aminoglycosides. There is positive evidence of human fetal risk during pregnancy. Neomycin 500 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 93 1177
Neomycin Sulfate
- Imprint
- 93 1177
- Strength
- 500 mg
- Color
- White
- Size
- 11.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Aminoglycosides
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA
- National Drug Code (NDC)
- 00093-1177
See also:
Xifaxan
Xifaxan (rifaximin) is used to treat travelers' diarrhea, irritable bowel syndrome with diarrhea ...
Constulose
Constulose is used for constipation, acute, constipation, chronic, hepatic encephalopathy
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Enulose
Enulose is used for constipation, acute, constipation, chronic, hepatic encephalopathy
Duphalac
Duphalac is a laxative used to treat chronic constipation by drawing water into the colon ...
Kristalose
Kristalose is used for constipation, acute, constipation, chronic, hepatic encephalopathy
Generlac
Generlac is used for constipation, acute, constipation, chronic, hepatic encephalopathy
Rifaximin
Rifaximin is used for crohn's disease, diarrhea, diarrhea, chronic, hepatic encephalopathy ...
More about neomycin
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Support group
- Drug class: aminoglycosides
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.